ReviewInterventional cardiology (London, England)2019
Update on the Current Landscape of Transcatheter Options for Tricuspid Regurgitation Treatment.
Review in Interventional cardiology (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05854095 (The Study for Evaluation of Acute Phase Safety and Efficacy of 'Pivot Bridge' to Short-term Treat Functional Tricuspid Regurgitation), which is not on this map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Study for Evaluation of Acute Phase Safety and Efficacy of 'Pivot Bridge' to Short-term Treat Functional Tricuspid Regurgitation : Multi-center, Open Label, Single Arm, Investigator Initiated Exploratory Pilot Study
Who cites it
20 citing papers in PubMed, 56 citations in OpenAlex.
- Transcatheter Tricuspid Valve Interventions to Manage Tricuspid Regurgitation: A Narrative Review.Reviews in cardiovascular medicine · 2025Review
- Beyond Medical Therapy-An Update on Heart Failure Devices.Journal of cardiovascular development and disease · 2024Review
- Percutaneous repair of tricuspid regurgitation.European heart journal supplements : journal of the European Society of Cardiology · 2024Article
- The Development of a Permanent Implantable Spacer with the Function of Size Adjustability for Customized Treatment of Regurgitant Heart Valve Disease.Bioengineering (Basel, Switzerland) · 2023Article
- Echocardiographic Imaging in Transcatheter Structural Intervention: An AAE Review Paper.JACC. Asia · 2023Review
- Biomechanical performance of the Bicaval Transcatheter System for the treatment of severe tricuspid regurgitation.Frontiers in bioengineering and biotechnology · 2023Article
- A Novel Device for Tricuspid Regurgitation Reduction Featuring 3-Dimensional Leaflet and Atraumatic Anchor: Pivot-TR System.JACC. Basic to translational science · 2022Article
- Novel treatment of atrial functional tricuspid regurgitation using transcatheter bicaval valve implantation (TricValve).AsiaIntervention · 2022Article
- Focus on Diagnosis and Prognosis to Guide Timing of Intervention in Valvular Heart Disease.Current cardiology reports · 2022Review
- Edge-to-Edge Repair for Tricuspid Valve Regurgitation. Preliminary Echo-Data and Clinical Implications from the Tricuspid Regurgitation IMAging (TRIMA) Study.Journal of clinical medicine · 2022Article
- Transcatheter edge-to-edge repair of tricuspid regurgitation in the Netherlands: state of the art and future perspectives.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2022Review
- Computationally Assessed 3D Anatomical Proximities and Spatial Relationships Among the Tricuspid Valve Annulus, Right Coronary Artery, and Triangle of Koch: Implications for Transcatheter Tricuspid Annuloplasty Repair.Structural heart : the journal of the Heart Team · 2022Article
- Roles of Cardiac Computed Tomography in Guiding Transcatheter Tricuspid Valve Interventions.Current cardiology reports · 2021Review
- Transcatheter Tricuspid Valve Intervention: Current Perspective.US cardiology · 2021Review
- Tricuspid Regurgitation in Left Ventricular Systolic Dysfunction: Marker or Target?Frontiers in cardiovascular medicine · 2021Review
- Tricuspid Valve Annuloplasty Alters Leaflet Mechanics.Annals of biomedical engineering · 2020Article
- Catheter-based treatment of tricuspid regurgitation: state of the art.Annals of translational medicine · 2020Review
- New Percutaneous Options for Tricuspid Intervention: How to Identify the Good Clinical Candidate.Frontiers in cardiovascular medicine · 2020Review
- Unsolved questions in prophylactic tricuspid valve repair and the possible role of transcatheter tricuspid intervention.American journal of cardiovascular disease · 2020Article
- Future Perspectives in Percutaneous Treatment of Tricuspid Regurgitation.Frontiers in cardiovascular medicine · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Most patients with severe tricuspid regurgitation lack treatment options because of prohibitive surgical risk. New transcatheter treatments under development and investigation might be able to address this unmet clinical need. This article gives an update on the landscape of devices for transcatheter tricuspid regurgitation treatment including different approaches (i.e. repair with leaflet approximation or annuloplasty and replacement using orthotopic or heterotopic valves) at different stages of development, from experimental to clinical trial. Repair devices such as the Cardioband or the MitraClip are leading the field with promising preliminary data and further trials are ongoing. However, with implantations of the Gate bioprosthesis, replacement devices are catching up. Potential advantages of different approaches and most recent data are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.